Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(11%)
Results Posted
60%(3 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_4
2
22%
Ph phase_1
4
44%
Ph phase_2
3
33%

Phase Distribution

4

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
4(44.4%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (44.4%)
Phase 23 (33.3%)
Phase 42 (22.2%)

Trials by Status

unknown111%
completed556%
terminated222%
recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9